Main Management ETF Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $60.4M | Buy |
|
|||||
|
2022
Q4 | $64M | Buy |
|
|||||
|
2022
Q3 | $37.7M | Buy |
|
|||||
|
2022
Q2 | $35M | Sell |
|
|||||
|
2022
Q1 | $42.5M | Buy |
|
|||||
|
2021
Q4 | $19.6M | Buy |
|
|||||
|
2021
Q3 | $20.9M | Buy |
|
|||||
|
2021
Q2 | $21.5M | Buy |
|
|||||
|
2021
Q1 | $20.4M | Sell |
|
|||||
|
2020
Q4 | $28.7M | Sell |
|
|||||
|
2020
Q3 | $22.8M | Sell |
|
|||||
|
2020
Q2 | $23.5M | Buy |
|
|||||
|
2020
Q1 | $15.5M | Sell |
|
|||||
|
2019
Q4 | $19.1M | Buy |
|
|||||
|
2019
Q3 | $14.7M | Sell |
|
|||||
|
2019
Q2 | $26.3M | Buy |
|
|||||
|
2019
Q1 | $25.5M | Buy |
|
|||||
|
2018
Q4 | $19.1M | Buy |
|
|||||
|
2018
Q3 | $24.1M | Buy |
|
|||||
|
2018
Q2 | $21.1M | Buy |
|
|||||
|
2018
Q1 | $16.5M | Buy |
|
|||||
|
2017
Q4 | $13.4M | Buy |
|